Dr. R Lobello studies liver cirrhosis, which is a serious condition where the liver becomes damaged and cannot function properly. He specifically looks at how blood ammonia levels, which can build up when the liver is not working well, relate to the severity of cirrhosis. By measuring these ammonia levels, he helps doctors determine how advanced a patient's liver damage may be and how best to monitor and treat them. This research benefits those suffering from liver cirrhosis and aims to improve their care and outcomes.
Key findings
Patients with mild liver cirrhosis had a median blood ammonia level of 45 mcM/L, while those with moderate and severe cases had levels of 66 and 108 mcM/L respectively (p < 0.001).
Higher ammonia levels indicate more severe liver damage and increased risk of complications in liver cirrhosis patients.
Monitoring blood ammonia can lead to better tailored treatment strategies for patients with liver cirrhosis.
Frequently asked questions
Does Dr. Lobello study liver cirrhosis?
Yes, he focuses on liver cirrhosis and its complications.
What treatments has Dr. Lobello researched?
He researches how monitoring blood ammonia levels can improve care for patients with liver cirrhosis.
Is Dr. Lobello's work relevant to patients with liver issues?
Yes, his research directly helps patients with liver cirrhosis and their healthcare providers.
Publications in plain English
Improved Clinical Outcomes With Elexacaftor/Tezacaftor/Ivacaftor in Patients With Cystic Fibrosis and Advanced Lung Disease: Real-World Evidence From an Italian Single-Center Study.
2025
Pharmacology research & perspectives
Perrotta N, Fiorito LA, Casini G, Gentile R, Vescovo R +5 more
Plain English This study looked at how well the drug combination Elexacaftor/Tezacaftor/Ivacaftor (ETI) works for patients with cystic fibrosis and serious lung issues. After two years, patients showed a 16% improvement in lung function and gained about 1.5 kg in weight, with a 58% reduction in lung exacerbations. This is important because it shows that ETI can lead to significant health benefits for these patients, making it a promising treatment option.
Who this helps: This helps patients with cystic fibrosis and advanced lung disease.
Plain English This study examined how a specific compound, LY294002, affects a particular channel in glioblastoma cells, which are aggressive brain tumors. The researchers found that LY294002 significantly reduces the activity of the KCa3.1 ion channel in these cells, which could help improve the effectiveness of cancer treatments. This finding is important because it suggests a way to potentially overcome resistance to chemotherapy and radiation in glioblastoma patients.
Who this helps: Patients with glioblastoma and their doctors.
In vitro activity of ceftaroline and ceftobiprole against methicillin-resistant Staphylococcus aureus with decreased susceptibility to vancomycin isolated in paediatric patients.
2018
Journal of chemotherapy (Florence, Italy)
Carnesecchi G, Lobello R, Liggieri L, Palmero C, Pescetto L +3 more
Plain English This study looked at how well two antibiotics, ceftaroline and ceftobiprole, work against a type of dangerous bacteria called methicillin-resistant Staphylococcus aureus (MRSA) in children. Researchers found that 64% of the MRSA strains were less sensitive to ceftaroline, while only 18% showed this for ceftobiprole, with just 1.4% of strains being fully resistant to ceftobiprole and none being resistant to ceftaroline. This matters because it reveals concerning levels of resistant strains in a hospital where these drugs had never been used, indicating a potential future challenge in treating these infections.
Who this helps: This helps doctors treating pediatric patients with MRSA infections.
Characterization of Staphylococcus aureus small colony variant strains isolated from Italian patients attending a regional cystic fibrosis care centre.
2015
The new microbiologica
Morelli P, De Alessandri A, Manno G, Marchese A, Bassi M +3 more
Plain English This study looked at a type of slow-growing bacteria called small colony variant Staphylococcus aureus found in cystic fibrosis (CF) patients in Italy. Researchers found that 27 out of 28 of these variants were dependent on thymidine, and they showed higher antibiotic resistance and a greater ability to form biofilms compared to normal strains. This matters because these variants are spreading among patients, which can complicate treatment and increase the risk of infections that are harder to manage.
Who this helps: This research benefits cystic fibrosis patients and their healthcare providers.
What are the implications of the spontaneous spleno-renal shunts in liver cirrhosis?
2009
BMC gastroenterology
Tarantino G, Citro V, Conca P, Riccio A, Tarantino M +4 more
Plain English This study looked at how spleno-renal shunts (blood vessels connecting the spleen and kidney) affect complications in patients with liver cirrhosis. Out of 129 patients examined, 18.5% had these shunts, and those patients had a higher rate of liver cancer (7.4%) compared to those without shunts, as well as lower blood flow in the spleen. Understanding this link is important because it could lead to better monitoring and treatment options for patients at risk of serious complications.
Who this helps: This research benefits patients with liver cirrhosis by highlighting the need for careful monitoring of those with spleno-renal shunts.
Blood ammonia levels in liver cirrhosis: a clue for the presence of portosystemic collateral veins.
2009
BMC gastroenterology
Tarantino G, Citro V, Esposito P, Giaquinto S, de Leone A +4 more
Plain English This study looked at the relationship between blood ammonia levels and the presence of abnormal veins in people with liver cirrhosis. The researchers found that patients with higher ammonia levels had more severe liver issues, with median ammonia levels of 45, 66, and 108 mcM/L for mild, moderate, and severe liver cirrhosis respectively (p < 0.001). This is important because by identifying patients with high ammonia levels, doctors can better monitor those at risk of serious complications, leading to better care.
Who this helps: Patients with liver cirrhosis and their healthcare providers.
The contribution of omental adipose tissue to adipokine concentrations in patients with the metabolic syndrome.
2007
Clinical and investigative medicine. Medecine clinique et experimentale
Tarantino G, Lobello R, Scopacasa F, Contaldo F, Pasanisi F +9 more
Plain English This study looked at the levels of certain substances in the blood that are linked to inflammation and blood vessel growth in overweight patients with metabolic syndrome compared to healthy individuals. It found that patients had higher levels of two important markers—vascular endothelial growth factor (VEGF) and interleukin-6 (IL6)—in their blood. Specifically, the patients' VEGF levels averaged 31.5 pg/mL compared to 21.35 pg/mL in healthy controls, and IL6 levels were 5.50 pg/mL compared to just 1.15 pg/mL in controls, showing a significant increase. These findings matter because they highlight how abdominal obesity can influence body processes related to inflammation and blood vessel formation, which is important for understanding and treating metabolic conditions.
Who this helps: This helps patients with metabolic syndrome and their doctors.
Estimation of bulky lymph nodes by power Doppler ultrasound scanning in patients with Hodgkin's lymphoma: a prospective study.
2006
Haematologica
Picardi M, Ciancia R, De Renzo A, Montante B, Ciancia G +8 more
Plain English This study looked at how well two imaging methods—clinical/computed tomography (CT) and power Doppler ultrasound—can identify large lymph nodes in 137 patients with Hodgkin's lymphoma. It found that CT identified bulky disease in 47% of patients, while power Doppler ultrasound detected it in only 20%. However, the findings showed that power Doppler ultrasound is a better predictor of treatment success, significantly linked to patients' chances of staying healthy after treatment.
Who this helps: This helps patients by providing a clearer understanding of their prognosis and treatment outcomes.
Randomized comparison of power Doppler ultrasound-directed excisional biopsy with standard excisional biopsy for the characterization of lymphadenopathies in patients with suspected lymphoma.
2004
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Picardi M, Gennarelli N, Ciancia R, De Renzo A, Gargiulo G +8 more
Plain English This study looked at two methods of performing lymph node biopsies in patients who might have lymphoma—one using standard techniques and the other using an advanced imaging technique called power Doppler ultrasound to guide the procedure. Researchers found that the ultrasound-guided method was more effective, detecting cancer in 87% of patients compared to 64% in the standard method, and also reduced the need for repeat biopsies. This is important because more accurate diagnosis can lead to earlier treatment and better outcomes for patients with lymphoma.
Who this helps: This helps patients suspected of having lymphoma.
Sorrentino P, Tarantino G, Conca P, Perrella A, Terracciano ML +4 more
Plain English This study looked at people with metabolic syndrome who had normal liver enzyme levels to see how common non-alcoholic fatty liver disease (NAFLD) and its more severe form, non-alcoholic steatohepatitis (NASH), were. Out of 80 patients, 58 had NASH, including 26 with liver damage (fibrosis) and 8 with serious liver problems (silent cirrhosis). The research found that traditional liver enzyme tests are not reliable indicators of liver disease severity in these patients, which is important for early diagnosis and treatment.
Who this helps: This helps patients with metabolic syndrome and their doctors identify liver issues earlier, even when liver enzyme levels appear normal.
Clinical evaluation of the imipenem/cilastatin combination in the therapy of severe infections in patients with malignant diseases.
1990
Drugs under experimental and clinical research
Cristiano P, Iovene MR, Simioli F, Pezza M, Raucci G +1 more
Plain English This study examined how effective the combination of imipenem and cilastatin is for treating severe infections in 30 hospitalized patients with cancer who had weakened immune systems. The treatment lasted about 9.6 days, and it successfully cured 23 out of 30 patients, which is about 77%. Additionally, the drugs eliminated almost 80% of the harmful bacteria found in these patients.
Who this helps: This helps cancer patients battling serious infections.
Clinical and pharmacokinetic study of cefotetan in biliary tract infections: preliminary report.
1988
Chemioterapia : international journal of the Mediterranean Society of Chemotherapy
Cristiano P, Lobello R, Iovene MR, De Ascentis G, Altucci P +2 more
Plain English This study looked at the effectiveness of a drug called cefotetan in treating biliary tract infections in 12 hospitalized patients. Of those treated, 11 (about 92%) fully recovered, while only one patient did not respond to the treatment. The drug was found to be present in high enough levels in the body to effectively kill the bacteria causing these infections, making cefotetan a reliable option for treatment.
Who this helps: This benefits patients suffering from biliary tract infections.
Cisapride versus placebo in reflux esophagitis. A multicenter double-blind trial.
1988
Journal of clinical gastroenterology
Baldi F, Bianchi Porro G, Dobrilla G, Iascone C, Lobello R +4 more
Plain English This study looked at the effects of a medication called cisapride on patients with esophagitis, a condition that causes inflammation of the esophagus. Out of 63 patients, only 3% of those taking cisapride saw no improvement after 6 weeks, compared to 43% of those on placebo. After 12 weeks, 63% of cisapride patients healed completely, while only 12% of the placebo group did, and cisapride users also reported fewer reflux symptoms and used fewer antacids.
Who this helps: This helps patients suffering from reflux esophagitis.
[Anatomo-surgical considerations on the inguinal region. I. The external oblique muscle].
1979
Archivio per le scienze mediche
Lobello R, Abate S, Ferulano GP
Plain English This study looked at the anatomy of the inguinal region (the groin area) by examining cadavers, focusing on the external oblique muscle. It found that while most information in anatomy textbooks is accurate, there are some important details that aren't well understood, such as certain features of the muscle and its role in hernias. Specifically, the external oblique muscle plays a secondary role in the development of hernias and is important for reinforcing surgical repairs.
Who this helps: This helps doctors performing hernia repairs.
[Anatomo-surgical considerations on the inguinal region. II. The internal oblique muscle and transverse muscle].
1979
Archivio per le scienze mediche
Abate S, Ferulano GP, Lobello R
Plain English This study looked at specific muscles in the groin—specifically the internal oblique and transverse muscles—to understand their role in inguinal hernias. The researchers found that certain weaknesses in these muscles could lead to recurring hernias after surgery, highlighting that variations in muscle structure are significant to this condition. Understanding these differences helps improve surgical techniques and patient outcomes.
Who this helps: This benefits patients undergoing hernia repair surgeries.
[Cancer of the gastric stump after duodeno-gastric resection].
1978
Minerva chirurgica
Lobello R, D'Armiento M
Plain English This study looked at a rare type of stomach cancer that can develop in patients who had surgery to remove parts of their stomach due to ulcers. Researchers examined 7 cases and found that using a special endoscopy technique called brushing is very effective for detecting cancer cells, showing positive results in all cases tested. This is important because it suggests that this technique should be regularly used to monitor stomach health in patients who have had similar surgeries.
Who this helps: Patients who have undergone gastric surgery.
Plain English This study examined how a surgical procedure called cardiomyotomy, used to treat achalasia (a swallowing disorder), affects reflux issues. Out of 83 patients, only 18 showed reflux when tested with barium, and most had a condition where tissue bulges through the diaphragm. The study found that a high-pressure area at the junction of the esophagus and stomach is more influenced by the diaphragm than by remaining muscle fibers, suggesting that the diaphragm plays a bigger role in preventing reflux than previously thought.
Who this helps: This helps patients with achalasia and their doctors in understanding post-surgery reflux mechanisms.
Lower oesophageal sphincter tone in patients with peptic stricture.
1978
Thorax
Lobello R, Stekelman M, Edwards DA
Plain English This study looked at how well the muscle at the bottom of the esophagus, known as the lower esophageal sphincter, works in 161 patients who have a narrowing in that area. The researchers found that in many cases, the sphincter could effectively close off the esophagus but could also relax when swallowing. Overall, 122 patients showed normal muscle tone, meaning their sphincter had the ability to both contract and relax as needed.
Who this helps: This helps patients with peptic stricture by improving understanding of how their sphincter works, which can inform treatment options.
[Serum gastrin levels in patients with recurrent peptic ulcer].
1977
Chirurgia italiana
Lobello R, D'Armiento M, Califano G
Plain English This study looked at how levels of gastrin, a hormone that helps with digestion, change in people who have recurring peptic ulcers after they eat a protein meal. Researchers tested 20 patients and found that most of them showed a significant increase in gastrin levels 15 and 45 minutes after eating, indicating that their bodies were producing more of this hormone in response to the meal. Understanding these changes can help doctors better manage treatment for patients with recurring peptic ulcers.
Who this helps: Patients with recurring peptic ulcers.
[Postoperative pulmonary complications following abdominal surgery. Study on the preventive use of a bronchosecretolytic agent associated with an antibiotic].
1975
Minerva chirurgica
Lobello R
Plain English This study looked at how to prevent breathing problems after abdominal surgery by using a treatment called Bisolvomycin along with antibiotics. Researchers found that this combination significantly reduced complications, especially in patients with pre-existing lung issues. This is important because it can help make recovery safer for patients after surgery.
Who this helps: Patients undergoing abdominal surgery, especially those with lung conditions.